Abhishek Maiti, M.D.
Department of Leukemia, Division of Cancer Medicine
About Dr. Abhishek Maiti
Dr. Abhishek Maiti is an Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas. He graduated from Nil Ratan Sircar Medical College in India, and completed internal medicine residency at the University of Texas, Houston, followed by a fellowship in hematology/oncology at MD Anderson Cancer Center.
Dr. Maiti's patient care and research focuses on developing novel therapies for leukemias. He has authored several peer-reviewed publications in leading medical journals and presented his research at national and international meetings. His work has received recognition from the American Society of Clinical Oncology, the European Hematology Association, the American Society of Hematology, the Society for Translational Oncology, and others. He has received prestigious national and international awards including the ASCO Young Investigator Award, the Future Leaders in Hematology Award, Leuka International Scholarship, ASCO Endowed Merit Award, the Shannon Timmins Endowed Fellowship, among others.
Present Title & Affiliation
Primary Appointment
Assistant Professor, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2010 | Nilratan Sircar Medical College and Hospital, Kolkata, IND, MD, Medicine and Surgery |
Postgraduate Training
| 2017-2020 | Clinical Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2014-2017 | Clinical Residency, The University of Texas Health Science Center, Houston, TX |
| 2010-2011 | Clinical Internship, Nilratan Sircar Medical College and Hospital, Kolkata |
Board Certifications
| 2020 | Oncology, American Board of Medical Specialties |
| 2020 | Hematology, American Board of Medical Specialties |
| 2017 | American Board of Internal Medicine |
Experience & Service
Academic Appointments
Summer Research Fellow, Department of Biological Chemistry, Division of National Science Academy, Indian Association for the Cultivation of Science, Kolkata, 2009 - 2009
ICMR Short Term Student, Department of Hematology, Nilratan Sircar Medical College and Hospital, Kolkata, 2008 - 2008
Other Appointments/Responsibilities
IRB Member, RICE University Institutional Review Board, Houston, TX, 2020 - Present
Fellowship Trustee, House Staff Association Executive Council, The University of Texas Health Science Center, Houston, TX, 2017 - 2018
Vice President, House Staff Association, The University of Texas Health Science Center, Houston, TX, 2016 - 2017
Institutional Committee Activities
Reviewer / Member, Scientific Review Committee # 1, 2022 - Present
Member, Senate Research Affairs Committee, 2021 - Present
Member, Academic and Planning Committee - Division of Education & Training, 2021 - Present
Co-Chair, Emil J Freireich Leukemia Hematology Grand Rounds, 2021 - Present
Member, Graduate Medical Education Committee, UTHSCH, 2017 - 2018
Member, House Staff Senate, 2015 - 2016
Resident Member, Texas Medical Association Cancer Committee, 2015 - 2017
Resident Member, Memorial Hermann Hospital Cancer Committee, 2015 - 2017
Resident Member, Harris Health/LBJ Hospital Cancer Committee, 2015 - 2017
Honors & Awards
| 2020 | ASCO Endowed Merit Award, ASCO Bristol-Myers Squibb |
| 2020 | ASCO Young Investigator Award, Conquer Cancer Foundation |
| 2020 | EHA Travel Grant Award, European Hematology Association |
| 2020 | Kimberly Patterson Fellowship for Excellence in Leukemia Research |
| 2020 | Abstract Achievement Award, American Society of Hematology |
| 2020 | FDA Fellows' Day Workshop |
| 2019 | Shannon Timmins Endowed Fellowship in Leukemia Research |
| 2019 | AACR Molecular Biology in Clinical Oncology Workshop, AACR |
| 2019 | Abstract Achievement Award, American Society of Hematology |
| 2019 | Society for Translational Oncology Fellows’ Award |
| 2018 | Methods in Clinical Cancer Research Workshop, AACR/ASCO |
| 2018 | Abstract Achievement Award, American Society of Hematology |
| 2018 | Leuka International Scholarship, European School of Hematology |
| 2017 | Best Research Poster, 2nd Position, American College of Physicians Texas Associates Day |
| 2017 | Best Abstract Award, Society of Hematologic Oncology |
| 2017 | Abstract Achievement Award, American Society of Hematology |
| 2017 | Future Leaders in Hematology Award for Clinical Research |
| 2015 | Best Presentation, Resident and Fellow Section, American Medical Association Annual Research Symposium |
| 2010 | Best Paper for Pulmonary Medicine Poster Session, International Medical Students’ Research Conference |
| 2009 | National Science Academies’ Summer Research Fellowship |
| 2008 | Indian Council of Medical Research, Short Term Studentship |
| 2003 | National Merit Scholarship, Government of India |
Selected Publications
Peer-Reviewed Articles
- Zeng Z, Maiti A, Herbrich S, Cai T, Cavazos A, Manzella T, Ma H, Hayes K, Matthews J, DiNardo CD, Daver NG, Konopleva MY. Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates antileukemia responses in acute myeloid leukemia. Cancer. e-Pub 2022. PMID: 36477735.
- Maiti A, DiNardo CD, Qiao W, et al.. Ten-day Decitabine with Venetoclax vs. Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score Matched Analysis. Cancer 127(22):4213-20, 2022.
- Short NJ, Macaron W, Kadia T, Dinardo C, Issa GC, Daver N, Wang S, Jorgensen J, Nguyen D, Bidikian A, Patel KP, Loghavi S, Konopleva M, Yilmaz M, Jabbour E, Maiti A, Abbas HA, Shpall E, Popat U, Al-Atrash G, Pierce S, Kantarjian HM, Ravandi F. Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. Am J Hematol 97(11):E408-E411, 2022. e-Pub 2022. PMID: 36054774.
- Daver NG, Maiti A, Kadia TM, Vyas P, Majeti R, Wei AH, Garcia-Manero G, Craddock C, Sallman DA, Kantarjian HM. TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. Cancer Discov 12(11):2516-2529, 2022. PMID: 36218325.
- Maiti A, Daver NG. Eprenetapopt in the Post-Transplant Setting: Mechanisms and Future Directions. J Clin Oncol:JCO2201505. e-Pub 2022. PMID: 36070541.
- Maiti A, Carter BZ, Andreeff M, Konopleva MY. Beyond BCL-2 Inhibition in Acute Myeloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway. Clin Lymphoma Myeloma Leuk. e-Pub 2022. PMID: 35490155.
- Maiti A, Daver NG. A nonstick marrow may help to fry leukemia. Blood 139(8):1119-1121, 2022. PMID: 35201330.
- Maiti A, Konopleva MY. How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia. Cancer J 28(1):2-13, 2022. PMID: 35072368.
- Venugopal S, Maiti A, DiNardo CD, Qiao W, Ning J, Loghavi S, Daver NG, Kadia TM, Rausch CR, Alvarado Y, Ohanian M, Sasaki K, Short NJ, Takahashi K, Yilmaz M, Ravandi F, Kantarjian HM, Konopleva MY. Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine. Leuk Lymphoma 62(14):3501-3505, 2021. e-Pub 2021. PMID: 34474640.
- Maiti A, Rausch CR, Cortes JE, Pemmaraju N, Daver NG, Ravandi F, Garcia-Manero G, Borthakur G, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Kadia TM, Takahashi K, Yilmaz M, Jain N, Kornblau S, Montalban Bravo G, Sasaki K, Andreeff M, Bose P, Ferrajoli A, Issa GC, Jabbour EJ, Masarova L, Thompson PA, Wang S, Konoplev S, Pierce SA, Ning J, Qiao W, Welch JS, Kantarjian HM, DiNardo CD, Konopleva MY. Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens. Haematologica 106(3):894-898, 2021. e-Pub 2021. PMID: 32499238.
- Maiti A, Qiao W, Sasaki K, Ravandi F, Kadia TM, Jabbour EJ, Daver NG, Borthakur G, Garcia-Manero G, Pierce SA, Montalbano KS, Pemmaraju N, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Takahashi K, Yilmaz M, Jain N, Kornblau SM, Andreeff M, Bose P, Ferrajoli A, Issa GC, Masarova L, Thompson PA, Rausch CR, Ning J, Kantarjian HM, DiNardo CD, Konopleva MY. Venetoclax with Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified by Risk of Treatment-related Mortality. Am J Hematol 96(3):282-291, 2021. e-Pub 2020. PMID: 33264443.
- Diao S, Nichols ED, DiNardo C, Konopleva M, Ning J, Qiao W, Maiti A, DiPippo AJ. Incidence of Tumor Lysis Syndrome in Patients with Acute Myeloid Leukemia Undergoing Low-Intensity Induction with Venetoclax. Am J Hematol 96(3):E65-E68, 2021. e-Pub 2020. PMID: 33259075.
- Bhugra P, Maiti A. Secondary Syphilis. N Engl J Med 383(14):1375, 2020. PMID: 32997911.
- DiNardo CD, Maiti A, Rausch CR, Pemmaraju N, Naqvi K, Daver NG, Kadia TM, Borthakur G, Ohanian M, Alvarado Y, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M, Bose P, Jabbour EJ, Takahashi K, Burger JA, Garcia-Manero G, Jain N, Kornblau SM, Thompson PA, Estrov Z, Masarova L, Sasaki K, Verstovsek S, Ferrajoli A, Weirda WG, Wang SA, Konoplev S, Chen Z, Pierce SA, Ning J, Qiao W, Ravandi F, Andreeff M, Welch JS, Kantarjian HM, Konopleva MY. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Lancet Haematol 7(10):e724-e736, 2020. e-Pub 2020. PMID: 32896301.
- Bhugra P, Maiti A. A 44-year-old man with cough, arthralgia, and fever. Eur J Intern Med 77:119-120, 2020. e-Pub 2020. PMID: 32418704.
- Maiti A, Cortes JE, Patel KP, Masarova L, Borthakur G, Ravandi F, Verstovsek S, Ferrajoli A, Estrov Z, Garcia-Manero G, Kadia TM, Nogueras-González GM, Skinner J, Poku R, DellaSala S, Luthra R, Jabbour EJ, O'Brien S, Kantarjian HM. Long-term results of frontline dasatinib in chronic myeloid leukemia. Cancer 126(7):1502-1511, 2020. e-Pub 2020. PMID: 31999839.
- Maiti A, Kantarjian HM, Popat V, Borthakur G, Garcia-Manero G, Konopleva MY, DiNardo CD, Verstovsek S, Andreeff M, Kadia TM, Ajufo HO, Goswamy RV, Blanco C, Velasquez M, Daver NG, Pemmaraju N, Pierce SR, Wierda WG, Kornblau SM, Ravandi F, Cortes JE. Clinical value of event-free survival in acute myeloid leukemia. Blood Adv 4(8):1690-1699, 2020. PMID: 32330243.
- Ball S, Das A, Vutthikraivit W, Edwards PJ, Hardwicke F, Short NJ, Borthakur G, Maiti A. Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Lymphoma Myeloma Leuk 20(2):87-97.e5, 2020. e-Pub 2019. PMID: 31787589.
- Maiti A, Franquiz MJ, Ravandi F, Cortes JE, Jabbour EJ, Sasaki K, Marx K, Daver NG, Kadia TM, Konopleva MY, Masarova L, Borthakur G, DiNardo CD, Naqvi K, Pierce S, Kantarjian HM, Short NJ. Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias. Acta Haematol 143(6):567-573, 2020. e-Pub 2020. PMID: 32289808.
- Roy B, Das A, Ashish K, Bandyopadhyay D, Maiti A, Chakraborty S, Stone ME, Philpotts LL, Nowak RJ, Patwa HS. Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis. Neurology 93(2):e143-e148, 2019. e-Pub 2019. PMID: 31167931.
- Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, Oo TH. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther 12(2):115-118, 2019. e-Pub 2018. PMID: 29409729.
- Ko H, Yan M, Gupta R, Kebbel K, Maiti A, Song J, Nates J, Overman MJ. Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit. Oncologist 24(4):483-490, 2019. e-Pub 2018. PMID: 30518614.
- Maiti A, Naqvi K, Kadia TM, Borthakur G, Takahashi K, Bose P, Daver NG, Patel A, Alvarado Y, Ohanian M, DiNardo CD, Cortes JE, Jabbour EJ, Garcia-Manero G, Kantarjian HM, Ravandi F. Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk 19(3):142-148.e1, 2019. e-Pub 2018. PMID: 30635233.
- Benton CB, Chien KS, Tefferi A, Rodriguez J, Ravandi F, Daver N, Jabbour E, Jain N, Alvarado Y, Kwari M, Pierce S, Maiti A, Hornbaker M, Santos MA, Martinez S, Siguero M, Zblewski D, Al-Kali A, Hogan WJ, Kantarjian H, Pardanani A, Garcia-Manero G. Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome. Hematol Oncol 37(1):96-102, 2019. e-Pub 2018. PMID: 30153704.
- Jiang Y, Maiti A, Kanaan Z. A Young Man with a Mass: Non-Early Precursor T-Cell Lymphoblastic Lymphoma. Am J Med 132(1):58-60, 2019. e-Pub 2018. PMID: 30138599.
- Short NJ, Kantarjian HM, Loghavi S, Huang X, Qiao W, Borthakur G, Kadia TM, Daver N, Ohanian M, Dinardo CD, Estrov Z, Kanagal-Shamanna R, Maiti A, Benton CB, Bose P, Alvarado Y, Jabbour E, Kornblau SM, Pemmaraju N, Jain N, Gasior Y, Richie MA, Pierce S, Cortes J, Konopleva M, Garcia-Manero G, Ravandi F. Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial. Lancet Haematol 6(1):e29-e37, 2019. e-Pub 2018. PMID: 30545576.
- Burns E, Anand K, Acosta G, Irani M, Chung B, Maiti A, Ibrahim I, Rice L. Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH). Case Rep Hematol 2019:3146965, 2019. e-Pub 2019. PMID: 30891320.
- King N, Kukreja K, Murzabdillaeva A, Ali Y, Willis J, Maiti A, Ma H, Bull J. A rare presentation of carcinosarcoma of the bone in a young female; response with gemcitabine and docetaxel. Clin Sarcoma Res 9:10, 2019. e-Pub 2019. PMID: 31304003.
- Ball S, Thein KZ, Maiti A, Nugent K. Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms. J Thromb Thrombolysis 45(4):516-528, 2018. PMID: 29404876.
- Herman A, Maiti A, Cherian SV, Estrada-Y-Martin RM. Heimlich Maneuver-Induced Diaphragmatic Rupture and Hiatal Hernia. Am J Med Sci 355(4):e13, 2018. e-Pub 2018. PMID: 29661360.
- Horn R, Maiti A, Cherian SV. An elderly man with hemolysis and myelophthisic anemia. Eur J Intern Med 48:e7-e8, 2018. e-Pub 2017. PMID: 28697949.
- Mohan V, Maiti A, Swaby MG, Cherian SV. Vasculitis due to levamisole-adulterated cocaine. Postgrad Med J 94(1107):61, 2018. e-Pub 2017. PMID: 28972099.
- Bhatia K, Maiti A, Chatterjee S. Vascular and Splenic Abnormalities in Heterotaxy Syndrome. Am J Med Sci 355(1):e1, 2018. e-Pub 2017. PMID: 29289273.
- Numan Y, Alfayez M, Maiti A, Alvarado Y, Jabbour EJ, Ferrajoli A, Konoplev SN, Kantarjian HM, Bose P. First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia. JCO Precis Oncol 2, 2018. e-Pub 2018. PMID: 31080940.
- Goswamy RV, Maiti A, Escobar MA. Unnecessary Use of Inferior Vena Cava Filters: A Teachable Moment. JAMA Intern Med 177(12):1847-1848, 2017. PMID: 29049483.
- Simkins A, Maiti A, Cherian SV, Trujillo DO, Estrada-Y-Martin RM. Mounier-Kuhn syndrome. Postgrad Med J 93(1104):642, 2017. e-Pub 2017. PMID: 28596443.
- Maiti A, Short NJ, Verstovsek S, Powers CA, Fullmer CA, Reyes SR, Bueso-Ramos CE. Quality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis. Leuk Lymphoma 58(10):2508-2510, 2017. e-Pub 2017. PMID: 28264600.
- Maiti A, Dhoble A. Takotsubo Cardiomyopathy. N Engl J Med 377(16):e24, 2017. PMID: 29045209.
- Maiti A, Cortes J, Ferrajoli A, Estrov Z, Borthakur G, Garcia-Manero G, Jabbour E, Ravandi F, O'Brien S, Kantarjian H. Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia. Leuk Lymphoma 58(9):1-6, 2017. e-Pub 2017. PMID: 28278723.
- Jabbour E, Guastad Daver N, Short NJ, Huang X, Chen HC, Maiti A, Ravandi F, Cortes J, Abi Aad S, Garcia-Manero G, Estrov Z, Kadia T, O'Brien S, Dabaja B, Bueso-Ramos C, Strati P, Bivins C, Pierce S, Kantarjian H. Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia. Am J Hematol 92(9):924-928, 2017. e-Pub 2017. PMID: 28556489.
- Maiti A, Nemati-Shafaee M, Msaouel P, Pagliaro LC, Jonasch E, Tannir NM, Shah AY. Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma. Clin Genitourin Cancer. e-Pub 2017. PMID: 28870517.
- Salem SA, Gurung S, Maiti A. Urine fluorescence in antifreeze poisoning. BMJ Case Rep 2017, 2017. e-Pub 2017. PMID: 28659374.
- Maiti A, Wanger A, Chavez V, Smith DT. Acute appendicitis caused by Schistosoma japonicum. J Infect Public Health 10(3):331-333, 2017. e-Pub 2016. PMID: 27283925.
- Simkins A, Maiti A, Cherian SV. Wunderlich Syndrome. Am J Med 130(5):e217-e218, 2017. e-Pub 2017. PMID: 28159184.
- Maiti A, Saha D, Das A. Emphysematous Pyelitis: An Entity Distinct from Emphysematous Pyelonephritis. Am J Med Sci 353(5):505, 2017. e-Pub 2016. PMID: 28502342.
- Maiti A, Cherian SV, Estrada-Y-Martin RM. Thoracic splenosis mimicking pleural mass: the importance of clinical history. QJM 110(4):241-242, 2017. PMID: 28073932.
- Mohan V, Bhavani S, Subramanian SK, Maiti A. Calcified cauliflower ear in relapsing polychondritis. BMJ Case Rep 2017, 2017. e-Pub 2017. PMID: 28432170.
- Maiti A, Cortes JE, Brown YD, Kantarjian HM. Phase I/II study of low-dose azacytidine in patients with chronic myeloid leukemia who have minimal residual disease while receiving therapy with tyrosine kinase inhibitors. Leuk Lymphoma 58(3):722-725, 2017. e-Pub 2016. PMID: 27658536.
- Maiti A, Terracina KA, Das A, Chatterjee S. A tale of two hearts. Postgrad Med J 93(1096):107, 2017. e-Pub 2016. PMID: 27466412.
- Yan MN, Maiti A, Mathews JS. A case of leukocytosis with hepatosplenomegaly. Eur J Intern Med 37:e5-e6, 2017. e-Pub 2016. PMID: 27539536.
- Kinahan H, Maiti A, Hess K, Dempsey J, Beatty L, Baldwin S, Hong DS, Naing A, Fu S, Tsimberidou AM, Piha-Paul S, Janku F, Karp D, Reddy S, Yennu S, Epner D, Bruera E, Meric-Bernstam F, Falchook G, Subbiah V. Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit. Oncology 92(1):14-20, 2017. e-Pub 2016. PMID: 27802448.
- Short NJ, Benton CB, Chen HC, Qiu P, Gu L, Pierce S, Brandt M, Maiti A, Min TL, Naqvi K, Quintas-Cardama A, Konopleva M, Kadia T, Cortes J, Garcia-Manero G, Ravandi F, Jabbour E, Kantarjian H, Andreeff M. Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy. Am J Hematol 91(12):1221-1226, 2016. e-Pub 2016. PMID: 27474808.
- Maiti A, Das A, Smith DT. Phlegmasia cerulea dolens. Postgrad Med J 92(1093):690, 2016. e-Pub 2016. PMID: 27274083.
- Das A, Maiti A, Sinha S. Antidepressant Prescription in the Geriatric Population: A Teachable Moment. JAMA Intern Med 176(11):1608-1609, 2016. PMID: 27668672.
- Maiti A, Das A, Saha D. Iron deficiency anemia with mucocutaneous lesions. Eur J Intern Med 33:e5-6, 2016. e-Pub 2016. PMID: 26912019.
- Maiti A, Smith DT, Das A. Dermatological manifestations of infective endocarditis. Postgrad Med J 92(1091):565, 2016. e-Pub 2016. PMID: 27147612.
- Petitto GS, Maiti A, Bhattacharjee M. The Computed Tomography Quadrate Lobe "Hot Spot" Sign. Am J Med Sci 352(3):e5, 2016. e-Pub 2016. PMID: 27650245.
- Subbiah V, Maiti A. Headache in a patient with renal cell carcinoma. Eur J Intern Med 32:e3-4, 2016. e-Pub 2016. PMID: 26905772.
- Maiti A, Das A. Kaposi Sarcoma of the Plantar Surface. Am J Med Sci 352(1):91, 2016. e-Pub 2016. PMID: 27432041.
- Laskar M, Das A, Maiti A. Raindrop Pigmentation in Chronic Arsenic Toxicity. Am J Med Sci 351(6):625, 2016. e-Pub 2016. PMID: 27238928.
- Maiti A, Short NJ, Kroll MH. Indiscriminate Testing for Heparin-Induced Thrombocytopenia: A Teachable Moment. JAMA Intern Med 176(5):592-3, 2016. PMID: 27043083.
- Bhattacharya S, Das A, Maiti A. A 28-year-old man with syncope, hypotension, and lethargy. Eur J Intern Med 30:e1-e2, 2016. e-Pub 2015. PMID: 26577224.
- Maiti A, Bhattacharjee M. Megaesophagus in Achalasia. Am J Med Sci 351(5):549, 2016. e-Pub 2016. PMID: 27140718.
- Maiti A, Bhattacharya S. A patient with cancer and nail pigmentation. BMJ 353:i2346, 2016. e-Pub 2016. PMID: 27142474.
- Maiti A, Das A. A man with altered mental status and metabolic acidosis. BMJ 353:i2338, 2016. e-Pub 2016. PMID: 27126444.
- Maiti A, Lodato RF. An abnormal post-procedure chest radiograph. BMJ 353:i2359, 2016. e-Pub 2016. PMID: 27130350.
- Maiti A, Das A, Chatterjee S. A man with breast discharge and headache. Eur J Intern Med 29:e3-4, 2016. e-Pub 2015. PMID: 26577222.
- Maiti A, Brown RE, Corn PG, Murthy R, Ganeshan DM, Tsimberidou AM, Subbiah V. Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates. Clin Genitourin Cancer 14(2):e187-93, 2016. e-Pub 2015. PMID: 26684814.
- Saha D, Basu A, Maiti A, Rodriguez E. Primary proximal epithelioid sarcoma of the lung successfully treated with pneumonectomy and adjuvant chemotherapy. BMJ Case Rep 2016, 2016. e-Pub 2016. PMID: 27045049.
- Maiti A, Saha D, Basu A. Type 4 Hiatal Hernia. Am J Med Sci 351(3):e5, 2016. PMID: 26992269.
- Maiti A, Chatterjee S. Turner syndrome: fifteen years' experience in India. J Obstet Gynaecol India 64(Suppl 1):121-3, 2014. e-Pub 2013. PMID: 25404835.
- Bandyopadhyay S, Dhua D, Maiti A, Maity PK. Intrathoracic schwannoma presenting with massive haemoptysis. J Assoc Physicians India 61(5):336, 2013. PMID: 24482947.
- Maiti A, Chatterjee S. Neuropsychiatric manifestations and their outcomes in chronic hypocalcaemia. J Indian Med Assoc 111(3):174-7, 2013. PMID: 24592758.
- Maiti A, Ghosh S. An unusual head computed tomography in an elderly patient with head trauma. Am J Med Sci 345(1):52, 2013. PMID: 22270394.
- Gupta P, Maiti A, Aich RK, Deb AR. Adrenal neuroblastoma in an adult. J Cancer Res Ther 9(1):96-8, 2013. PMID: 23575083.
- Maiti A, Nandi K, Chatterjee S. Management of gestational diabetes mellitus in a public hospital setting in India: lessons from a minimalist approach. Diabetes Res Clin Pract 95(2):e34-6, 2012. e-Pub 2011. PMID: 22129654.
- Maiti A, Chakraborti A, Chakraborty P, Mishra S. Subclinical haemorrhagic tendency exists in patients with β-thalassaemia major in early childhood. Australas Med J 5(2):152-5, 2012. e-Pub 2012. PMID: 22905058.
- Maiti A, Chatterjee S. Congenital adrenal hyperplasia: an Indian experience. J Paediatr Child Health 47(12):883-7, 2011. e-Pub 2011. PMID: 21658148.
Abstracts
- Daver N, Jayastu J, Maiti A, Loghavi S, Kadia TM, DiNardo CD, Pemmaraju N, Jabbour E, Montalban-Bravo G, Tang G, Sasaki K, Borthakur B, Yilmaz M, Alvarez J, Pierce SA, Nogueras GM, González, Ning J, Issa GC, Andreeff M, Abbas H, Ravandi F, Garcia-Manero G, Kantarjian HM. Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML. Blood 140(1):141-144, 2022.
- Bazinet A, Kadia TM, Short NJ, Borthakur G, Wang SA, Loghavi S, Jorgensen JL, Patel KP, DiNardo CD, Daver N, Alvarado Y, Haddad F, Pierce SA, Nogueras-González GM, Maiti A, Andreeff M, Jabbour E, Konopleva M, Huang X, Kantarjian HM, Ravandi F. Achievement of Measurable Residual Disease (MRD) Negativity Supersedes Treatment Intensity in Predicting the Outcome of Patients with Acute Myeloid Leukemia. Blood 140(1):2267-2269, 2022. e-Pub 2022.
- Yamatani K, Maiti A, Watanabe T, Saito K, Hayes K, Kinjo S, Ikeo K, Miida T, Kimura S, DiNardo CD, Su X, Tabe Y, Konopleva MY. Biomarkers of Clinical Resistance to Decitabine and Venetoclax Therapy Inferred By Transcriptome and Methylation Analyses. Blood 140(1):3097-3098, 2022. e-Pub 2022.
- Maiti A, DiNardo CD, Ohanian M, Pemmaraju N, Daver N, Borthakur G, Ravandi F, Issa GC, Garcia-Manero G, Jain N, Kadia TM, Masarova L, Wierda WG, Yilmaz M, Alvarado Y, Jabbour E, Short NJ, Takahashi K, Loghavi S, Patel KP, Montalbano K, Pierce SA, Bivins CA, Mehta RS, Alatrash G, Popat UR, Kebriaei P, Oran B, Shpall EJ, Champlin RE, Kantarjian HM, Konopleva MY. Long-Term Outcomes of Acute Myeloid Leukemia Following Allogeneic Stem-Cell Transplantation after Decitabine and Venetoclax: Subgroup Analysis of a Phase II Trial. Blood 140(1):7725-7728, 2022.
- Maiti A, DiNardo CD, Daver N, Kadia TM, Borthakur G, Short NJ, Pemmaraju N, Ohanian M, Alvarado Y, Takahashi K, Pierce S, Patel K, Jabbour E, Garcia-Manero G, Ravandi F, Kantarjian HM, Konopleva MY. Evolution of Genomic Landscape in Acute Myeloid Leukemia after Decitabine and Venetoclax. Blood(2021 Nov 23;138:1304), 2021.
- Chatterjee S, Maiti A. An Interesting constellation of dextrocardia and tetralogy of Fallot presenting for the first time in middle age with UTI, 2009.
Grant & Contract Support
| Title: | Anti-PR1 Antibody Therapy for Advanced Myeloid Leukemias |
| Funding Source: | Conquer Cancer Foundation, ASCO |
| Role: | Principal Investigator |
| Title: | Protocol 2022-0581: Understanding the combinational effect of CDC7 inhibition with hydroxyurea in acute myeloid leukemia |
| Funding Source: | Lin BioSciences Inc |
| Role: | Principal Investigator |
| Title: | Targeting MerTK using novel antibody drug conjugate RGX-019 in AML |
| Funding Source: | Inspirna |
| Role: | Co-Investigator |
| Title: | Protocol 2022-0542: Phase I study of IGM-8444 with Azacitidine and Venetoclax, or Birinpant in Relapsed, Refractory, or Newly Diagnosed AML |
| Funding Source: | IGM Biosciences |
| Role: | Principal Investigator |
| Title: | Protocol 2021-0877 A first-in-human study of CD123 NK Cell Engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia or high risk-myelodysplasia |
| Funding Source: | Sanofi-Aventis |
| Role: | Principal Investigator |
| Title: | Protocol 2019-0591: Phase 1b Study of Venetoclax in Combination with Intensive Induction and Consolidation Chemotherapy in Newly Diagnosed Acute Myelogenous Leukemia |
| Funding Source: | Dana Farber Partners Cancer Care, Inc |
| Role: | Principal Investigator |
| Title: | Protocol 2021-0248: Phase II Study of Venetoclax in Combination with 10-day Oral Decitabine in Relapsed/Refractory Acute Myeloid Leukemia |
| Funding Source: | Astex Pharmaceuticals |
| Role: | Principal Investigator |
| Title: | Protocol 2021-0451: Phase 2, Study of BST-236 Older/Unfit Patients with Relapsed or Refractory Acute Myeloid Leukemia or HR-MDS |
| Funding Source: | BioSight Ltd |
| Role: | Principal Investigator |
| Title: | Protocol 2022-0509: A Phase I/II Dose Escalation and Expansion Study of BST-236 plus Venetoclax in Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Induction Chemotherapy |
| Funding Source: | BioSight Ltd |
| Role: | Principal Investigator |
| Title: | Protocol 2017-0912: A Phase II Study of Venetoclax in Combination with 10-day Decitabine in Newly Diagnosed Elderly or Relapsed/Refractory Acute Myeloid Leukemia, Relapsed High-Risk Myelodysplastic Syndrome and Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Funding Source: | M.D. Anderson Cancer Center |
| Role: | Principal Investigator |